FDA Inspection 1308088 — Moderna TX Clinical Biomarker Laboratory
The FDA completed an inspection of Moderna TX Clinical Biomarker Laboratory on February 13, 2026 in Norwood, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 13, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Norwood, MA (United States)
Additional Details
Sponsor, Contract Research Organization